BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 30200227)

  • 1. ELF3, ELF5, EHF and SPDEF Transcription Factors in Tissue Homeostasis and Cancer.
    Luk IY; Reehorst CM; Mariadason JM
    Molecules; 2018 Aug; 23(9):. PubMed ID: 30200227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the ETS transcription factor ELF3 in the retinal pigment epithelium.
    Jobling AI; Fang Z; Koleski D; Tymms MJ
    Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3530-7. PubMed ID: 12407165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ELF5 isoform expression is tissue-specific and significantly altered in cancer.
    Piggin CL; Roden DL; Gallego-Ortega D; Lee HJ; Oakes SR; Ormandy CJ
    Breast Cancer Res; 2016 Jan; 18(1):4. PubMed ID: 26738740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The uncovering of ESE-1 in human neutrophils: implication of its role in neutrophil function and survival.
    Lee CM; Gupta S; Parodo J; Wu J; Marshall JC; Hu J
    Genes Immun; 2015; 16(5):356-61. PubMed ID: 25906252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ETS transcription factor ESE-1 transforms MCF-12A human mammary epithelial cells via a novel cytoplasmic mechanism.
    Prescott JD; Koto KS; Singh M; Gutierrez-Hartmann A
    Mol Cell Biol; 2004 Jun; 24(12):5548-64. PubMed ID: 15169914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E74 like ETS transcription factor 3 (ELF3) is a negative regulator of epithelial- mesenchymal transition in bladder carcinoma.
    Gondkar K; Patel K; Krishnappa S; Patil A; Nair B; Sundaram GM; Zea TT; Kumar P
    Cancer Biomark; 2019; 25(2):223-232. PubMed ID: 31104013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanopore Sequencing Unveils Diverse Transcript Variants of the Epithelial Cell-Specific Transcription Factor Elf-3 in Human Malignancies.
    Boti MA; Adamopoulos PG; Tsiakanikas P; Scorilas A
    Genes (Basel); 2021 May; 12(6):. PubMed ID: 34072506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of ELF3 facilitates cell growth and metastasis through PI3K/Akt and ERK signaling pathways in non-small cell lung cancer.
    Wang H; Yu Z; Huo S; Chen Z; Ou Z; Mai J; Ding S; Zhang J
    Int J Biochem Cell Biol; 2018 Jan; 94():98-106. PubMed ID: 29208568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells.
    Yeung TL; Leung CS; Wong KK; Gutierrez-Hartmann A; Kwong J; Gershenson DM; Mok SC
    Oncotarget; 2017 Mar; 8(10):16951-16963. PubMed ID: 28199976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SAM pointed domain ETS factor (SPDEF) regulates terminal differentiation and maturation of intestinal goblet cells.
    Noah TK; Kazanjian A; Whitsett J; Shroyer NF
    Exp Cell Res; 2010 Feb; 316(3):452-65. PubMed ID: 19786015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ETS transcription factor ESE1/ELF3 orchestrates a positive feedback loop that constitutively activates NF-κB and drives prostate cancer progression.
    Longoni N; Sarti M; Albino D; Civenni G; Malek A; Ortelli E; Pinton S; Mello-Grand M; Ostano P; D'Ambrosio G; Sessa F; Garcia-Escudero R; Thalmann GN; Chiorino G; Catapano CV; Carbone GM
    Cancer Res; 2013 Jul; 73(14):4533-47. PubMed ID: 23687337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of ETS transcription factor-mediated tumorigenesis.
    Kar A; Gutierrez-Hartmann A
    Crit Rev Biochem Mol Biol; 2013; 48(6):522-43. PubMed ID: 24066765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ETS transcription factor ELF3 (ESE-1) is a cell cycle regulator in benign and malignant prostate.
    Archer LK; Frame FM; Walker HF; Droop AP; McDonald GLK; Kucko S; Berney DM; Mann VM; Simms MS; Maitland NJ
    FEBS Open Bio; 2022 Jul; 12(7):1365-1387. PubMed ID: 35472129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation of OCT4 by the ETS transcription factor ESE-1 in NCCIT human embryonic carcinoma cells.
    Park SW; Do HJ; Ha WT; Han MH; Yang HM; Lee SH; Song H; Kim NH; Kim JH
    Biochem Biophys Res Commun; 2014 Jul; 450(2):984-90. PubMed ID: 24971534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of ELF3 immunoexpression is useful for detecting oral squamous cell carcinoma but not for distinguishing between grades of epithelial dysplasia.
    AbdulMajeed AA; Dalley AJ; Farah CS
    Ann Diagn Pathol; 2013 Aug; 17(4):331-40. PubMed ID: 23643910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of epithelial-specific ETS-1 (ESE-1) as a tumor suppressor and molecular target of green tea compound, EGCG.
    Ha T; Lee J; Lou Z; Lee BS; Kim CH; Lee SH
    Mol Carcinog; 2019 Jun; 58(6):922-932. PubMed ID: 30676667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPDEF inhibits prostate carcinogenesis by disrupting a positive feedback loop in regulation of the Foxm1 oncogene.
    Cheng XH; Black M; Ustiyan V; Le T; Fulford L; Sridharan A; Medvedovic M; Kalinichenko VV; Whitsett JA; Kalin TV
    PLoS Genet; 2014 Sep; 10(9):e1004656. PubMed ID: 25254494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial-specific ETS-1 (ESE1/ELF3) regulates apoptosis of intestinal epithelial cells in ulcerative colitis via accelerating NF-κB activation.
    Li L; Miao X; Ni R; Miao X; Wang L; Gu X; Yan L; Tang Q; Zhang D
    Immunol Res; 2015 Jun; 62(2):198-212. PubMed ID: 25926267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelium-specific ETS transcription factor-1 regulates NANOG expression and inhibits NANOG-induced proliferation of human embryonic carcinoma cells.
    Park SW; Do HJ; Choi W; Lim DS; Park KH; Kim JH
    Biochimie; 2021 Jul; 186():33-42. PubMed ID: 33865902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E74-Like Factor 3 Is a Key Regulator of Epithelial Integrity and Immune Response Genes in Biliary Tract Cancer.
    Suzuki M; Saito-Adachi M; Arai Y; Fujiwara Y; Takai E; Shibata S; Seki M; Rokutan H; Maeda D; Horie M; Suzuki Y; Shibata T; Kiyono T; Yachida S
    Cancer Res; 2021 Jan; 81(2):489-500. PubMed ID: 33293429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.